Results of a Double-Blind, Randomized, Dose-Titration, Placebo Controlled Multicenter Trial (Sco/Bia-2093-203 Study) on Safety and Efficacy of Eslicarbazepine Acetate (Bia 2-093) for Acute Manic Episodes Associated with Biopolar I Disorder
4Th Biennial Conference of the International-Society-For-Bipolar-Disorders, Date: MAR 17-20, 2010, Location: Sao Paulo, BRAZIL, Sponsors: Int Soc Bipolar Disorders
